The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.

Ross JS, Slodkowska EA, Symmans WF, Pusztai L, Ravdin PM, Hortobagyi GN

Open source

DOI
10.1634/theoncologist.2008-0230
Published
2009 Apr
Container
The oncologist
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 25/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1634/theoncologist.2008-0230,
  title = {The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.},
  author = {Ross JS and Slodkowska EA and Symmans WF and Pusztai L and Ravdin PM and Hortobagyi GN},
  year = {2009},
  journal = {The oncologist},
  doi = {10.1634/theoncologist.2008-0230},
  url = {https://doi.org/10.1634/theoncologist.2008-0230}
}

RIS

TY  - JOUR
TI  - The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.
AU  - Ross JS
AU  - Slodkowska EA
AU  - Symmans WF
AU  - Pusztai L
AU  - Ravdin PM
AU  - Hortobagyi GN
PY  - 2009
JO  - The oncologist
DO  - 10.1634/theoncologist.2008-0230
UR  - https://doi.org/10.1634/theoncologist.2008-0230
ER  - 

APA

JS, R., EA, S., WF, S., L, P., PM, R., & GN, H. (2009). The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.. The oncologist. https://doi.org/10.1634/theoncologist.2008-0230

Source records